RE: Impending change27 Jul 2025 19:55
Hulver, Blastoid,
It has indeed been a long time to infuse P3, I believe there have been ‘complications’ since the infusion was manufactured by Hemogenyx (as RNSd). My guess is they have gone back to find a new P3 but that is speculation on my part.
What I am more confident of is that P3 is on the ‘critical path’ to a deal and to the paediatric trial starting - my interpretation of VS’s words at the AGM was Q4 and that was before the P3 delay so….
As you both say, clarification from VS would be most helpful.